LIXT

Lixte Biotechnology Holdings, Inc. is a clinical-stage biotechnology company based in East Setauket, New York, focused on developing innovative therapies for serious diseases through its proprietary biomarker technology. With a robust pipeline addressing critical unmet needs in oncology and neurodegenerative disorders, Lixte is pioneering advancements in precision medicine. The company's unique ability to identify and modulate specific enzymes sets it apart in the biotechnology landscape, presenting a compelling investment opportunity for institutional investors seeking to support cutting-edge therapeutic innovations.